Mitesco (MITI) Receivables - Other (2012 - 2021)
Mitesco (MITI) reported Receivables - Other of $26163.0 for Q2 2021, down 71.27% on a QoQ basis from $91066.0 in Q4 2017.
Mitesco (MITI) has 4 years of Receivables - Other data on file, last reported at $26163.0 in Q2 2021.
- Quarterly Receivables - Other changed N/A year-over-year to $26163.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $26163.0 (changed N/A YoY) and the FY2017 annual result came in at $91066.0, changed N/A from the prior year.
- Receivables - Other declined to $26163.0 in Q2 2021 per MITI's latest filing, from $91066.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $91066.0 in Q4 2017 and bottomed at $26163.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mitesco | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 26,163.00 |
| Jun 30, 2021 | 26,163.00 |
| Dec 31, 2017 | 91,066.00 |
| Dec 31, 2017 | 91,066.00 |
| Dec 31, 2013 | 900,000.00 |
| Dec 31, 2013 | 900,000.00 |
| Jun 30, 2012 | 273,333.00 |
| Jun 30, 2012 | 273,333.00 |